NCT06038383

Brief Summary

Patients with chronic kidney diseases, especially those requiring hemodialysis, are characterized by an increased risk of numerous morbidities. This is a condition that significantly impacts the patient's quality of life, leads to dependence, and involves high-cost treatment. The physical condition of chronic kidney disease patients falls well below the recommendations set by the World Health Organization, indicating effective difficulties in the approaches used for implementing physical activity programs. New approaches must be considered. Physical activity through virtual reality can foster greater social integration of patients with physical exercise during hemodialysis, enabling improved quality of life and decreased frailty levels for these individuals due to its playful and motivational nature. Objective: To assess changes in heart rate variability modulation and the quality of life of chronic kidney disease patients undergoing virtual reality-based exercise during hemodialysis sessions. Methods: A longitudinal, controlled, randomized crossover clinical trial. The chronic kidney disease groups will be divided into two groups, Group A (GA) and Group B (GB). Group GA will engage in 10 interventions, with each intervention involving the completion of 3 sessions of a Virtual Reality (VR) game lasting 5 minutes each, totaling 15 minutes of exercise. Group GB will participate in 10 interventions, with each intervention comprising 15 minutes of physical exercise on a cycle ergometer, referred to here as conventional exercise. After the initial 10 interventions, the groups will switch exercises; that is, GA will cease VR interventions and begin another 10 interventions with conventional exercise, while GB will stop conventional exercise interventions and start another 10 interventions with VR. The Kidney Disease Quality of Life Short Form questionnaire, Beck's Anxiety and Depression Inventory, and the International Physical Activity Questionnaire will also be administered to all groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 14, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

1.2 years

First QC Date

August 29, 2023

Last Update Submit

June 23, 2025

Conditions

Keywords

hemodialysisphysical exercisevirtual realityRenal Insufficiencyheart rate variability

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability behavior during interventions with Virtual Reality and Stationary Bike while in hemodialysis.

    Measurements made by heart rate variability indices, using both linear and non-linear measurements, using a chest trap that captures the R-R intervals in milliseconds.

    4 days

Secondary Outcomes (4)

  • Blood pressure during interventions with Virtual Reality and Stationary Bike while in hemodialysis

    20 days

  • Heart rate during interventions with Virtual Reality and Stationary Bike while in hemodialysis

    20 days

  • Respiratory rate during interventions with Virtual Reality and Stationary Bike while in hemodialysis

    20 days

  • Oxygen saturation during interventions with Virtual Reality and Stationary Bike while in hemodialysis

    20 days

Study Arms (4)

Group A - Intervention with Virtual Reality (VR)

EXPERIMENTAL

Group of people with kidney disease that enrolled the intervention with VR during hemodialysis.

Device: Group A - Intervention with Virtual Reality (VR)

Group B - Intervention with Stationary Bike (SB)

ACTIVE COMPARATOR

Group of people with kidney disease that enrolled the intervention with SB during hemodialysis.

Device: Group B - Intervention with Stationary Bike (SB)

Group A - Intervention with Stationary Bike (SB) - Crossover

EXPERIMENTAL

Group of people with kidney disease that enrolled the intervention with SB during hemodialysis, after the period of washout.

Device: Group A - Intervention with Stationary Bike (SB) - Crossover

Group B - Intervention with Virtual Reality (VR) - Crossover

ACTIVE COMPARATOR

Group of people with kidney disease that enrolled the intervention with VR during hemodialysis, after the period of washout.

Device: Group B - Intervention with Virtual Reality (VR) - Crossover

Interventions

Group of people with kidney disease that performed VR intervention during hemodialysis.

Group A - Intervention with Virtual Reality (VR)

Group of people with kidney disease that performed SB intervention during hemodialysis.

Group B - Intervention with Stationary Bike (SB)

Group of people with kidney disease that performed SB intervention during hemodialysis after the washout period.

Group A - Intervention with Stationary Bike (SB) - Crossover

Group of people with kidney disease that performed VR intervention during hemodialysis after the washout period.

Group B - Intervention with Virtual Reality (VR) - Crossover

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with diagnosed chronic renal insufficiency requiring hemodialysis at any classification level.
  • Age over 18 years.
  • Possession of medical clearance for participating in physical exercise.
  • Ability for lower limb movement without affecting dialysis treatment.

You may not qualify if:

  • Acute use of medications that affect the cardiovascular system and/or alter the function of the nervous system, unless they are part of the disease treatment protocol and are part of the patient's routine.
  • Reports of persistent pain and fatigue arising after the start of exercise training.
  • Changes in the type of renal treatment during the protocol application period.
  • Absence from three consecutive exercise training sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comitê de Etica da Universidade Federal de São Paulo

São Paulo, 04.023-900, Brazil

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicMotor ActivityRenal Insufficiency

Interventions

Cross-Over Studies

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Talita D Silva, PhD

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 14, 2023

Study Start

September 1, 2023

Primary Completion

November 1, 2024

Study Completion

December 1, 2024

Last Updated

June 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations